Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Editorial team
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
Scottish CMO Symbiosis strengthens US presence
Scottish CMO Symbiosis strengthens US presence
Appoints Dr Thomas Scullion as US Business Development Manager
David Lescuyer joins SkyePharma as Executive Vice President, Oral Business
David Lescuyer joins SkyePharma as Executive Vice President, Oral Business
He will be responsible for Skyepharma’s Oral Business including, after 30 June, the manufacturing operations in Saint-Quentin Fallavier, France
Kymab hires leaders in immuno-oncology, infectious disease and blood disorders
Kymab hires leaders in immuno-oncology, infectious disease and blood disorders
Appointments bring internationally recognised expertise to strengthen Kymab’s key therapeutic areas
Adapt Pharma names Mike Kelly as President of US operations
Adapt Pharma names Mike Kelly as President of US operations
He contributes more than 25 years of pharmaceutical expertise to Adapt executive team
Dr Richard Butt to become CEO of Apollo Therapeutics
Dr Richard Butt to become CEO of Apollo Therapeutics
He will join the investment fund from Pfizer Neusentis
Dr Belinda Quinn appointed as Chief Executive of the Precision Medicine Catapult
Dr Belinda Quinn appointed as Chief Executive of the Precision Medicine Catapult
Quinn has been Chief Medical Officer of the organisation for the past six months
Nigel Bond joins Brother executive management team
Nigel Bond joins Brother executive management team
Follows acquisition of Domino Printing Sciences by Japanese firm
Merck appoints Maya Martinez-Davis as Global Head of Oncology
Merck appoints Maya Martinez-Davis as Global Head of Oncology
Her role will include defining global oncology strategies and delivering therapeutic launches
President of Vetter Development Services USA elected to board of German American Chamber of Commerce of the Midwest
President of Vetter Development Services USA elected to board of German American Chamber of Commerce of the Midwest
Susanne Resatz will help GACC Midwest further promote and expand bilateral trade and investment between the Midwest and Germany
Probiodrug appoints Mark Booth as Chief Business Officer
Probiodrug appoints Mark Booth as Chief Business Officer
The move expands the German firm's Management Board
Novavax announces management promotion
Novavax announces management promotion
Iksung Cho has been named as Vice President, Biostatistics
Daiichi Sankyo appoints Antoine Yver as Global Head, Oncology Research and Development
Daiichi Sankyo appoints Antoine Yver as Global Head, Oncology Research and Development
He will lead all global R&D across the oncology therapeutic area
New Technical Officer for ReFaC
New Technical Officer for ReFaC
Kim Shillington joins the UK firm
ESMO appoints first Chief Medical Officer
ESMO appoints first Chief Medical Officer
New position reflects ESMO’s rapid growth and follows extensive six-month selection process
Paragon Bioservices appoints Bill Thomas as Chief Technology Officer
Paragon Bioservices appoints Bill Thomas as Chief Technology Officer
Vaccines industry veteran was most recently with MassBiologics
Cypralis hires Dr Michael Peel as Chief Scientific Officer
Cypralis hires Dr Michael Peel as Chief Scientific Officer
He joins the UK life sciences firm from Scynexis, where he was Director of Discovery
Previous
1
…
99
100
101
102
(current)
103
104
105
…
216
Next
Trending Articles
New Managing Director for Shimadzu Europa
Dr. Florian Geistmann (pictured) takes over as Managing Director of Shimadzu Europa, succeeding Jürgen Semmler, who has retired after five years at the helm of the European organisation and more than 39 years in the company in total
BioDuro appoints Greg Makara to lead discovery chemistry
BioDuro has appointed Greg Makara, PhD, as Senior Vice President, Lead Discovery Chemistry, as the contract research, development and manufacturing organisation (CRDMO) looks to strengthen its early-stage drug discovery capabilities.
EyeC expands OEM growth with new business development manager
Rigel Gallegos will lead the development of EyeC’s OEM and system integrator business
Three new commercial appointments for Symbiosis
Symbiosis Pharmaceutical Services has expanded its commercial team with three new appointments as the specialist aseptic fill-finish CDMO targets further growth across Asia-Pacific, the Middle East and Southern Europe
Lonza nominates Pearl Huang to board
Lonza has nominated Pearl Huang as an independent member of its Board of Directors, bringing extensive pharmaceutical and biotechnology experience and expertise in drug discovery and innovation